Stress Testing Liquidity: Insights into Midcap and Smallcap Mutual Funds

By

In the nuanced world of mutual fund investments, liquidity stands as a pivotal factor, particularly in the realms of midcap and smallcap funds. Recent studies offer a granular look into how these funds perform under liquidity stress tests, challenging conventional wisdom and providing valuable insights for investors.

Insightful Liquidity Patterns

The liquidity timeframe required for mutual funds to liquidate a significant portion of their portfolios varies notably between small-cap and mid-cap funds. For instance, liquidating 25% of small-cap funds ranges from as quickly as 2 days (Edelweiss Mutual Fund, Motilal Oswal) to as long as 25 days (SBI Mutual Fund). Similarly, liquidating 50% extends up to 60days for SBI Mutual Fund, indicating a broader liquidity spectrum.

Mid-cap funds exhibit their liquidity nuances with liquidation periods for 25% of the portfolio being as swift as 1 day (Edelweiss Mutual Fund) and extending up to 17 days (Kotak Mutual Fund). For 50% portfolio liquidation, the timeframe stretches to 34 days for Kotak Mutual Fund, showcasing significant diversity in liquidity capabilities.

Size vs. Liquidity: A Surprising Dynamic

The correlation between a fund's size and its liquidity is not as straightforward as one might assume. For instance, the Nippon India Small Cap Fund, with an AUM of Rs. 46,000 crore, can liquidate half of its portfolio in 27 days, contrasting sharply with the SBI Small Cap Fund’s 60 days for the same, despite its smaller AUM of Rs. 25,500 crore.

Investor Concentration and Its Implications

Investor concentration within a fund significantly influences its liquidity. Small cap funds with high top 10 investor concentrations (over 10%) such as ITI, Mahindra Manulife, and Bandhan show casevaried liquidity capabilities. In the midcap domain, funds like MOSL and JM Midcap mirror this trend. However, the dispersion of investments across a wider base in larger funds helps mitigate the risk of massive, concurrentredemptions.

SEBI’s Stress Test Mandate: Enhancing Transparency

SEBI’s directive for liquidity stress testing, particularly for midcap and small cap funds, is a proactive step towards ensuring market stability. These tests are designed to simulate conditions of sudden market sentiment shifts and large-scale redemption requests, providing a clearer picture of a fund’s liquidity resilience. The results, which include the time required to liquidate significant portions of the portfolio under stress, offer critical insights for investors and fund managers alike.

Beyond Liquidity: A Balanced Investment Approach

While liquidity remains a crucial factor in selecting a mutual fund, it's imperative to view it within a broader investment framework. The performance, valuation, and risk associated with a fund are equally important. An illiquid stock, for instance, does not necessarily equate to a poor investment. It's the balance of these factors that shapes a sound investment strategy.

 

Disclaimer:

Mool Capital Limited is a SEBI Registered Research Analyst having registration no. INH000012449. This report has been prepared by Mool Capital Pvt. Ltd. and is solely for information of the recipient only. The report must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report should not be construed as an invitation or solicitation to do business with Mool Capital. Mool Capital and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.

Latest Analysis by Mool Capital
Explore All Analysis

5 days trial then ₹1,999/month

Stock Analysis
Premium Articles
Capital Markets Data
Global Coverage
AI Powered Workspace

Subscribe
Coming Soon

Everything on Plus
AI Document Generation

Custom Builds

Private Cloud
Database Connections
Custom Documents

Contact Sales

5 days trial then ₹10,999/year

Premium Articles
Stock Analysis
AI Powered Workspace
Capital Markets Data
Global Coverage

Subscribe
Coming Soon

Everything on Plus
AI Document Generation

Custom Builds

Private Cloud
Database Connections
Custom Documents

Contact Sales